Rho

Rho, a global, privately-held full-service contract research organization (CRO) headquartered in NC’s Research Triangle Park. Rho provides a full range of drug development services from program strategy through clinical trials and marketing applications. For more than 38 years, Rho has been a trusted partner to some of the industry’s most innovative pharmaceutical, biotechnology and medical device companies, as well as academic and government organizations. Experience is a big deal to us; it’s the foundation of everything we do. We’re experienced, creative problem-solvers who provide devoted clinical development services. We work intentionally to create an experience that completely changes your mind about what it means to work with a CRO. And equally important, our personal experiences drive why we do everything we can to heal the world.

Engaging a CRO? Ask Sites What They Think First Rho

Engaging a CRO? Ask Sites What They Think First Rho
Leveraging Interim Analyses to Optimize Late Phase Clinical Trial Decision Making

Leveraging Interim Analyses to Optimize Late Phase Clinical Trial Decision Making
Should Biopharma Prepare for a Future Parkinson’s Wave?

Should Biopharma Prepare for a Future Parkinson’s Wave?
Building Bridges: Patient Advocacy Groups Can Be Vital Partners in Clinical Research Trials

Building Bridges: Patient Advocacy Groups Can Be Vital Partners in Clinical Research Trials
Parkinson’s Disease: Addressing Personalized Medicine’s Complexity Problem

Parkinson’s Disease: Addressing Personalized Medicine’s Complexity Problem
Kate York

Kate York
Life as a Biostatistician at Rho

Life as a Biostatistician at Rho
Partnering for Success: Doing Study Start-Up Right in the Context of Decentralized Studies

Partnering for Success: Doing Study Start-Up Right in the Context of Decentralized Studies
Expanded Access Webinar

Expanded Access Webinar
Collaboration in a Changing Landscape During COVID-19

Collaboration in a Changing Landscape During COVID-19
Expedited US FDA Development and Approval Programs for Serious Conditions

Expedited US FDA Development and Approval Programs for Serious Conditions
Hindsight is so 2020: Getting Ahead of CNS Trial Enrollment in a Rapidly Changing Clinical Landscape

Hindsight is so 2020: Getting Ahead of CNS Trial Enrollment in a Rapidly Changing Clinical Landscape
Strategies to Avoid Enrollment Delays Webinar

Strategies to Avoid Enrollment Delays Webinar
Mitigating Covid-19 through a hybrid decentralized clinical trials approach

Mitigating Covid-19 through a hybrid decentralized clinical trials approach
ALS Awareness

ALS Awareness
Potential COVID-19 Products: Choosing the Right Path with FDA

Potential COVID-19 Products: Choosing the Right Path with FDA
[Webinar] Managing the Risks of Implementing E6R2

[Webinar] Managing the Risks of Implementing E6R2
Are you really ready for your end of phase 2 meeting?

Are you really ready for your end of phase 2 meeting?
Improving Diversity in Clinical Research

Improving Diversity in Clinical Research
Challenges with Fast Enrolling Post-Operative Acute Pain Studies

Challenges with Fast Enrolling Post-Operative Acute Pain Studies
Early Patient Involvement in Clinical Trial Design

Early Patient Involvement in Clinical Trial Design
Expect More

Expect More
The Evolving Role of Clinical Data Management

The Evolving Role of Clinical Data Management